Geode Capital Management’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $159M | Buy |
3,681,580
+178,686
| +5% | +$7.72M | 0.01% | 754 |
|
|
2025
Q1 | $121M | Buy |
3,502,894
+85,201
| +2% | +$2.95M | 0.01% | 860 |
|
|
2024
Q4 | $93.8M | Buy |
3,417,693
+3,744
| +0.1% | +$103K | 0.01% | 1039 |
|
|
2024
Q3 | $86.9M | Buy |
3,413,949
+123,540
| +4% | +$3.15M | 0.01% | 1079 |
|
|
2024
Q2 | $83.4M | Buy |
3,290,409
+427,564
| +15% | +$10.8M | 0.01% | 1040 |
|
|
2024
Q1 | $88.5M | Buy |
2,862,845
+148,677
| +5% | +$4.6M | 0.01% | 994 |
|
|
2023
Q4 | $110M | Buy |
2,714,168
+202,988
| +8% | +$8.2M | 0.01% | 813 |
|
|
2023
Q3 | $66.2M | Buy |
2,511,180
+91,810
| +4% | +$2.42M | 0.01% | 1034 |
|
|
2023
Q2 | $41.6M | Buy |
2,419,370
+166,212
| +7% | +$2.86M | ﹤0.01% | 1377 |
|
|
2023
Q1 | $37.4M | Buy |
2,253,158
+187,251
| +9% | +$3.1M | ﹤0.01% | 1388 |
|
|
2022
Q4 | $15.7M | Buy |
2,065,907
+102,030
| +5% | +$777K | ﹤0.01% | 1935 |
|
|
2022
Q3 | $19.5M | Sell |
1,963,877
-6,569
| -0.3% | -$65.3K | ﹤0.01% | 1755 |
|
|
2022
Q2 | $17.9M | Buy |
1,970,446
+185,870
| +10% | +$1.69M | ﹤0.01% | 1840 |
|
|
2022
Q1 | $18.1M | Sell |
1,784,576
-142,835
| -7% | -$1.45M | ﹤0.01% | 1960 |
|
|
2021
Q4 | $32.1M | Sell |
1,927,411
-19,674
| -1% | -$328K | ﹤0.01% | 1642 |
|
|
2021
Q3 | $91.3M | Buy |
1,947,085
+123,147
| +7% | +$5.77M | 0.01% | 854 |
|
|
2021
Q2 | $111M | Buy |
1,823,938
+160,981
| +10% | +$9.81M | 0.02% | 742 |
|
|
2021
Q1 | $102M | Buy |
1,662,957
+453,236
| +37% | +$27.9M | 0.02% | 742 |
|
|
2020
Q4 | $86M | Buy |
1,209,721
+51,066
| +4% | +$3.63M | 0.01% | 774 |
|
|
2020
Q3 | $43.5M | Buy |
1,158,655
+425,720
| +58% | +$16M | 0.01% | 993 |
|
|
2020
Q2 | $23.9M | Buy |
732,935
+10,198
| +1% | +$333K | 0.01% | 1377 |
|
|
2020
Q1 | $21M | Buy |
722,737
+375,359
| +108% | +$10.9M | 0.01% | 1261 |
|
|
2019
Q4 | $12.2M | Buy |
347,378
+11,930
| +4% | +$418K | ﹤0.01% | 1874 |
|
|
2019
Q3 | $7.2M | Buy |
+335,448
| New | +$7.2M | ﹤0.01% | 2153 |
|